NCT05451095View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether BI 474121 Can Reverse the Memory Problems Caused by Ketamine

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 7, 2022

Primary Completion Date

June 5, 2023

Study Completion Date

June 20, 2023

Conditions
Healthy
Interventions
DRUG

BI 474121

BI 474121

DRUG

Placebo

Placebo

DRUG

Ketamine hydrochloride

Ketamine hydrochloride

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05451095 - A Study in Healthy Men to Test Whether BI 474121 Can Reverse the Memory Problems Caused by Ketamine | Biotech Hunter | Biotech Hunter